1. Systematic drug repositioning through mining adverse event data in ClinicalTrials.gov
   Eric Wen Su et al, 2017, PeerJ CrossRef
2. Combination therapy with telmisartan and parecoxib induces regression of endometriotic lesions
   Anca Nenicu et al, 2017, British Journal of Pharmacology CrossRef
3. Approaches Toward Targeting Matrix Metalloproteases for Prognosis and Therapies in Gynecological Cancer: MicroRNAs as a Molecular Driver
   Anuradha Pandit et al, 2022, Frontiers in Oncology CrossRef
4. Repurposed Drugs in Gastric Cancer
   Diana Araújo et al, 2022, Molecules CrossRef
5. Pharmacological Utility of PPAR Modulation for Angiogenesis in Cardiovascular Disease
   Nicole Wagner et al, 2023, International Journal of Molecular Sciences CrossRef
6. Telmisartan Influences the Antiproliferative Activity of Linoleic Acid in Human Colon Cancer Cells
   Magdalena Mielczarek-Puta et al, 2020, Nutrition and Cancer CrossRef
7. Telmisartan Inhibits Cell Proliferation and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inducing S-Phase Arrest In Vitro and In Vivo
   Takanori Matsui et al, 2019, International Journal of Molecular Sciences CrossRef
8. The potential anticancer activities of telmisartan – a literature review
   Andriana Hadjiyianni et al, 2023, Annales Academiae Medicae Silesiensis CrossRef
9. Dual function of activated PPARγ by ligands on tumor growth and immunotherapy
   Mingjun Chen et al, 2024, Medical Oncology CrossRef
10. Nuclear receptors in ovarian cancer: changing paradigms in cancer therapeutics
    Anjana Sajeev et al, 2024, Frontiers in Oncology CrossRef
11. Evidence of Omics, Immune Infiltration, and Pharmacogenomic for SENP1 in the Pan-Cancer Cohort
    Somayye Taghvaei et al, 2021, Frontiers in Pharmacology CrossRef
12. Antihypertensive Drug Use and the Risk of Ovarian Cancer Death among Finnish Ovarian Cancer Patients—A Nationwide Cohort Study
    Eerik E. E. Santala et al, 2021, Cancers CrossRef
13. Repurposing of Chronically Used Drugs in Cancer Therapy: A Chance to Grasp
    Mohamad Ali Hijazi et al, 2023, Cancers CrossRef
14. Expanding telmisartan’s therapeutic horizon: exploring its multifaceted mechanisms beyond cardiovascular disorders
    Yogesh S. Ahire et al, 2024, Future Journal of Pharmaceutical Sciences CrossRef
15. Telmisartan induces osteosarcoma cells growth inhibition and apoptosis via suppressing mTOR pathway
    Chao Wang et al, 2018, Open Life Sciences CrossRef
16. Telmisartan-Induced Cytotoxicity via G₂/M Phase Arrest in Renal Cell Carcinoma Cell Lines
    Yoshie Tsujiya et al, 2021, Biological and Pharmaceutical Bulletin CrossRef